Advertisement
Screener

Whitnell & Co. Historic Quarter Change: Foreign Stocks, Reduced

Whitnell & Co. historic quarter change: Foreign Stocks, Reduced

In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 13 quarters from 2013-06-30 to 2016-09-30, Whitnell & Co. opened 105 positions, added to 59, reduced 52 and sold out of 57.

  • Q3 2016: Stock TEVA; Country of operation —; Class ADR; Shares before 32,052.
  • Q3 2016: Stock BP; Country of operation —; Class SPONSORED ADR; Shares before 5,354.
  • Q3 2016: Stock SNY; Country of operation —; Class SPONSORED ADR; Shares before 336.
  • Q3 2016: Stock BCS; Country of operation —; Class ADR; Shares before 605.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1569173), 13 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-10-26); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-08); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-04-28); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-04); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-10); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-10); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-14); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-01-28); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-10); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-07); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-05); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-13); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-12). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2012-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q3 2016TEVA
TEVA PHARMACEUTICAL INDS LTD
ADR32,05230,828-1,224$1,610,000$1,418,000-$192,0002016-10-26
Q3 2016BP
BP PLC
SPONSORED ADR5,3541,354-4,000$190,000$48,000-$142,0002016-10-26
Q3 2016SNY
SANOFI
SPONSORED ADR336200-136$14,000$8,000-$6,0002016-10-26
Q3 2016BCS
BARCLAYS PLC
ADR605396-209$5,000$3,000-$2,0002016-10-26
Q3 2016ORANY
ORANGE
FranceSPONSORED ADR376247-129$6,000$4,000-$2,0002016-10-26
Q2 2016TEVA
TEVA PHARMACEUTICAL INDS LTD
ADR32,05332,052-1$1,715,000$1,610,000-$105,0002016-08-08
Q2 2016FMS
FRESENIUS MED CARE AG&CO KGA
SPONSORED ADR12854-74$6,000$2,000-$4,0002016-08-08
Q2 2016NVO
NOVO-NORDISK A S
ADR266196-70$14,000$11,000-$3,0002016-08-08
Q2 2016MFG
MIZUHO FINL GROUP INC
SPONSORED ADR2,1041,716-388$6,000$5,000-$1,0002016-08-08
Q1 2016TEVA
TEVA PHARMACEUTICAL INDS LTD
ADR32,59132,053-538$2,139,000$1,715,000-$424,0002016-04-28
Q1 2016VOD
VODAFONE GROUP PLC NEW
SPNSR ADR NO PAR1,712466-1,246$55,000$15,000-$40,0002016-04-28
Q1 2016NVS
NOVARTIS A G
SPONSORED ADR1,3831,230-153$119,000$89,000-$30,0002016-04-28
Q1 2016TM
TOYOTA MOTOR CORP
SP ADR REP2COM21358-155$26,000$6,000-$20,0002016-04-28
Q1 2016HSBC
HSBC HLDGS PLC
SPON ADR NEW414175-239$16,000$5,000-$11,0002016-04-28
Q1 2016BP
BP PLC
SPONSORED ADR5,2445,174-70$164,000$156,000-$8,0002016-04-28
Q1 2016MUFG
MITSUBISHI UFJ FINL GROUP IN
SPONSORED ADR1,689928-761$11,000$4,000-$7,0002016-04-28
Q1 2016BTI
BRITISH AMERN TOB PLC
SPONSORED ADR14084-56$15,000$10,000-$5,0002016-04-28
Q1 2016SHG
SHINHAN FINANCIAL GROUP CO L
SPN ADR RESTRD236125-111$8,000$4,000-$4,0002016-04-28
Q1 2016RIO
RIO TINTO PLC
SPONSORED ADR281157-124$8,000$4,000-$4,0002016-04-28
Q1 2016NICE
NICE SYS LTD
SPONSORED ADR542-52$3,000$0-$3,0002016-04-28
Q1 2016SONY
SONY CORP
ADR NEW282160-122$7,000$4,000-$3,0002016-04-28
Q1 2016WPP
WPP PLC NEW
ADR8757-30$10,000$7,000-$3,0002016-04-28
Q1 2016NVO
NOVO-NORDISK A S
ADR274266-8$16,000$14,000-$2,0002016-04-28
Q1 2016BBVA
BANCO BILBAO VIZCAYA ARGENTA
SPONSORED ADR858599-259$6,000$4,000-$2,0002016-04-28
Q1 2016SNY
SANOFI
SPONSORED ADR302262-40$13,000$11,000-$2,0002016-04-28
Q1 2016TELFY
TELEFONICA S A
SpainSPONSORED ADR521380-141$6,000$4,000-$2,0002016-04-28
Q1 2016WIT
WIPRO LTD
SPON ADR 1 SH474312-162$5,000$4,000-$1,0002016-04-28
Q1 2016E
ENI S P A
SPONSORED ADR217158-59$6,000$5,000-$1,0002016-04-28
Q1 2016PKX
POSCO
SPONSORED ADR205125-80$7,000$6,000-$1,0002016-04-28
Q4 2015TEVA
TEVA PHARMACEUTICAL INDS LTD
ADR32,79132,591-200$1,851,000$2,139,000+$288,0002016-02-04
Q2 2015TEVA
TEVA PHARMACEUTICAL INDS LTD
ADR31,37831,303-75$1,955,000$1,850,000-$105,0002015-08-10
Q2 2015BP
BP PLC
SPONSORED ADR6,9264,926-2,000$271,000$197,000-$74,0002015-08-10
Q1 2015TEVA
TEVA PHARMACEUTICAL INDS LTD
ADR31,82831,378-450$1,830,000$1,955,000+$125,0002015-05-14
Q1 2015HSBC
HSBC HLDGS PLC
SPON ADR NEW3,8502,000-1,850$182,000$85,000-$97,0002015-05-14
Q1 2015BP
BP PLC
SPONSORED ADR7,4266,926-500$283,000$271,000-$12,0002015-05-14
Q4 2014BP
BP PLC
SPONSORED ADR8,4267,426-1,000$370,000$283,000-$87,0002015-01-28
Q4 2014HSBC
HSBC HLDGS PLC
SPON ADR NEW4,3503,850-500$221,000$182,000-$39,0002015-01-28
Q3 2014TEVA
TEVA PHARMACEUTICAL INDS LTD
ADR34,42831,478-2,950$1,805,000$1,692,000-$113,0002014-11-10
Q3 2014NVS
NOVARTIS A G
SPONSORED ADR350200-150$32,000$19,000-$13,0002014-11-10
Q2 2014NVS
NOVARTIS A G
SPONSORED ADR900350-550$77,000$32,000-$45,0002014-08-07
Q2 2014TEVA
TEVA PHARMACEUTICAL INDS LTD
ADR34,82834,428-400$1,840,000$1,805,000-$35,0002014-08-07
Q2 2014HSBC
HSBC HLDGS PLC
SPON ADR NEW4,8704,350-520$248,000$221,000-$27,0002014-08-07
Q1 2014TEVA
TEVA PHARMACEUTICAL INDS LTD
ADR35,20334,828-375$1,411,000$1,840,000+$429,0002014-05-05
Q1 2014SIEGY
SIEMENS A G
SPONSORED ADR6,9506,450-500$963,000$872,000-$91,0002014-05-05
Q4 2013BP
BP PLC
SPONSORED ADR13,7188,426-5,292$577,000$410,000-$167,0002014-02-13
Q4 2013SIEGY
SIEMENS A G
SPONSORED ADR7,0256,950-75$847,000$963,000+$116,0002014-02-13
Q4 2013HSBC
HSBC HLDGS PLC
SPON ADR NEW4,7704,370-400$259,000$241,000-$18,0002014-02-13
Q4 2013NVS
NOVARTIS A G
SPONSORED ADR900750-150$69,000$60,000-$9,0002014-02-13
Q4 2013TEVA
TEVA PHARMACEUTICAL INDS LTD
ADR37,57835,203-2,375$1,420,000$1,411,000-$9,0002014-02-13
Q3 2013TEVA
* TEVA PHARMACEUTICAL INDS LTD
ADR39,02837,578-1,450$1,530,000$1,420,000-$110,0002013-11-12
Q3 2013HSBC
* HSBC HLDGS PLC
SPON ADR NEW5,1704,770-400$268,000$259,000-$9,0002013-11-12
Q3 2013NVS
* NOVARTIS A G
SPONSORED ADR950900-50$67,000$69,000+$2,0002013-11-12

Similar Firms

Firm NameCountry13F ValueHoldings
Not available yet